Abstract
Transgender patients treated with masculinizing hormone therapy (MHT) for gender affirmation may be at higher risk of developing acne following hormone initiation. We sought to examine the incidence and severity of acne in patients treated with MHT and factors which may predict development of acne. We conducted a retrospective cohort study using electronic medical records from a community health center which provides care to the LGBTQIA+ population for patients who started MHT between 2014 and 2017 (n=1,054).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
